Evidence map›Paper›PMID 41395584›Full record

ReviewGlobal challenges (Hoboken, NJ)2025

Plant Growth-Promoting Rhizobacteria and Bacterial Biocontrol Agents in Tomato Disease Management: Mechanisms, Applications, and Omics Perspectives.

Mateka Patience Modiba, Thomas Bell, Olubukola Oluranti Babalola

Abstract readReview
In one paragraph

Review in Global challenges (Hoboken, NJ), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Tailoring Cellulose Derivative Gel Matrices forGels (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mateka Patience ModibaFood Security and Safety Focus Area Faculty of Natural and Agricultural Sciences North-West University Mmabatho South Africa.ORCID https://orcid.org/0000-0003-3717-6336
Thomas BellDepartment of Life Sciences Imperial College London Silwood Park Campus Buckhurst Road, Ascot Berkshire SL5 7PY UK.ORCID https://orcid.org/0000-0002-2615-3932
Olubukola Oluranti BabalolaFood Security and Safety Focus Area Faculty of Natural and Agricultural Sciences North-West University Mmabatho South Africa.ORCID https://orcid.org/0000-0003-4344-1909

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant diseases, agricultural intensification, and climatic catastrophes such as drought have all has a significant impact on agricultural production in recent years. For decades, synthetic agrochemicals have been the primary tool for disease management and yield enhancement. However, their use poses significant environmental and health risks. There are many studies on plant growth-promoting rhizobacteria (PGPR) and bacterial biocontrol agents (BCA) as eco-friendly alternatives to synthetic agrochemicals. This review synthesizes current knowledge on the direct and indirect mechanisms by which PGPR and BCA enhance tomato growth and suppress pathogens. Although some of these PGPR and BCA are known, their mechanisms are not completely understood. Emerging omics approaches, which include genomics, transcriptomics, proteomics, and metabolomics, are highlighted as powerful tools for elucidating plant-microbe interactions and guiding next-generation biocontrol strategies. By critically examining overlapping mechanisms and applications, this review clarifies the complementary roles of PGPR, BCA, and "omics" and identifies research gaps for more consistent and scalable use in agriculture.

Indexed as

biological control agentsconventional farmingorganic farmingPGPRplant healthtomato diseases

Identifiers

PMID41395584
PMCPMC12697087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.